HilleVax, Inc. Annual Operating Income (Loss) in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
HilleVax, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2021 to 2023.
  • HilleVax, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$26.4M, a 22.2% increase year-over-year.
  • HilleVax, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$159M, a 37.3% decline year-over-year.
  • HilleVax, Inc. annual Operating Income (Loss) for 2023 was -$133M, a 105% decline from 2022.
  • HilleVax, Inc. annual Operating Income (Loss) for 2022 was -$65.1M, a 21.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$133M -$68.2M -105% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 -$65.1M -$11.7M -21.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 -$53.4M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.